1. bookVolume 66 (2019): Issue 1 (June 2019)
Journal Details
License
Format
Journal
First Published
25 Nov 2011
Publication timeframe
2 times per year
Languages
English
Copyright
© 2020 Sciendo

Is gentamicin administered to individual patients in optimal doses already at the beginning of therapy?

Published Online: 26 Dec 2019
Page range: 11 - 18
Received: 24 Sep 2018
Accepted: 11 Jan 2019
Journal Details
License
Format
Journal
First Published
25 Nov 2011
Publication timeframe
2 times per year
Languages
English
Copyright
© 2020 Sciendo

Introduction A gentamicin dose, which the physicians select, frequently does not take any pharmacokinetic parameters into consideration.

Keywords

[1] Martin J, Barras M, Ah Yui N, Kirkpatrick C, Kubler P, No R: Gentamicin monitoring practices in teaching hospitals – time to undertake the necessary randomised controlled trial. J Clinic Toxicol. 2012;2(8):1–5.Search in Google Scholar

[2] Durante-Mangoni E, Grammaticos A, Utili R, Falagas ME: Do we still need the aminoglycosides? Int J Antimicrob Agents. 2009;33(3):201–205.Search in Google Scholar

[3] Gómolka M, Niemczyk S: How to safely and effectively administer aminoglycoside antibiotics. Pol. Merkur. Lekarski. 2014;36(214):225–228.Search in Google Scholar

[4] Solomkin JS, Mazuski JE, Bradley JS et al. Diagnosis and management of complicated intra-abdominal infection in adults and children: guidelines by the Surgical Infection Society and the Infectious Diseases Society of America. Surg Infect. 2010;11:79–109.Search in Google Scholar

[5] Thomson AH, Duncan N, Silverstein B, Alcock S, Jodrell D: Development of gudelines for gentamicin dosing. J Antimicrob Chemother. 1996;38(5):885–893.Search in Google Scholar

[6] Cox ZL, Nelsen CL, Waitman LR, McCoy JA, Peterson JF: Clinical Decision Support Improves Initial Dosing and Monitoring of Tobramycin and Amikacin. American Society of Health-System Pharmacist. 2011;68(7): 624–632.Search in Google Scholar

[7] Fonzo-Christie C, Guignard B, Zaugg C et al.: Impact of clinical Decision Support Guidelines on Therapeutic Drug Monitoring of Gentamicin in Newborns. Ther Drug Monit. 2014;36(5):656–662.Search in Google Scholar

[8] Barza M, Ioannidis JP, Cappelleri JC, Lau J et al.: Single and multiple daily doses of aminoglycosides a meta-analysis. BMJ. 1996;10(312):338–345.Search in Google Scholar

[9] Nezic L, Derungs A, Bruggisser M, Tschudin-Sutter S, Krähenbühl S, Haschke M: Therapeutic drug monitoring of once daily aminoglycoside dosing: comparison of two methods and investigation of the optimal blood sampling strategy. Eur J Clin Pharmacol. 2014;70(7):829–837.Search in Google Scholar

[10] Radigan EA, Gilchrist NA, Miller MA: Managment of aminoglycosides in the intensive care unit. J Intensive Care Med. 2010;26(6):327–342.Search in Google Scholar

[11] Wong G, Sime FB, Lipman, J, Roberts JA: How do we use therapeutic drug monitoring to improve outcome from severe infections in critically ill patients? BMC Infect Dis. 2014;14:288.Search in Google Scholar

Plan your remote conference with Sciendo